ASVRX
Price
$10.56
Change
+$0.14 (+1.34%)
Updated
Aug 3 closing price
Net Assets
2.99B
JDSRX
Price
$26.18
Change
-$0.04 (-0.15%)
Updated
Jul 31 closing price
Net Assets
1.27B
Interact to see
Advertisement

ASVRX vs JDSRX

ASVRX vs JDSRX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. JDSRX commentary
Aug 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and JDSRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 3B vs. JDSRX (1.27B). ASVRX pays higher dividends than JDSRX: ASVRX (0.42) vs JDSRX (0.00). ASVRX was incepted earlier than JDSRX: ASVRX (16 years) vs JDSRX (17 years). JDSRX (1.73) is less costly to investors than ASVRX (1.58). ASVRX is a more actively managed with annual turnover of: 42.00 vs. JDSRX (37.00). ASVRX (2500) and JDSRX (2500) have matching initial minimum investment requirements. JDSRX annual gain was more profitable for investors over the last year : 24.21 vs. ASVRX (11.75). JDSRX return over 5 years is better than : 12.43 vs. ASVRX (-1.09).
ASVRXJDSRXASVRX / JDSRX
Total Expense Ratio1.581.7391%
Annual Report Gross Expense Ratio1.581.7391%
Fund Existence16 years17 years-
Gain YTD21.44516.327131%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets3B1.27B236%
Annual Yield % from dividends0.420.00-
Returns for 1 year11.7524.2149%
Returns for 3 years8.1514.9854%
Returns for 5 years-1.0912.43-9%
Returns for 10 years31.8336.1788%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIEIX27.930.22
+0.79%
JPMorgan Equity Income A
HFYTX15.98N/A
N/A
Hartford Schroders Intl Multi-Cp Val R5
SPMIX29.23-0.04
-0.14%
Shelton S&P Midcap Index Investor
GSMAX20.62-0.03
-0.15%
Goldman Sachs Small/Mid Cap Growth A
TRACX22.78-0.04
-0.18%
PGIM Quant Solutions Small-Cap Val C